The stability of cannabinoid products is a critical factor for manufacturers aiming to deliver...
Demystifying the PMTA Pathway for Nicotine Pouches: Key Challenges and Opportunities
The U.S. Food and Drug Administration (FDA) has set out a rigorous regulatory framework for nicotine-containing products, with the Premarket Tobacco Product Application (PMTA) pathway being a critical requirement for market access. For nicotine...
Results - 43 Blogs
Nicotine pouches are exciting products that can help support worldwide tobacco harm reduction....
Broughton welcomes the US Food and Drug Administration’s (FDA) decision to authorize ZYN nicotine...
Allergies concerns highlights need to meet stringent regulations ~
The cannabis industry is on track for transformative growth in 2025, driven by advancements in...
The pharmaceutical industry is set to experience transformative developments in 2025, driven by...
The tobacco harm reduction (THR) industry is undergoing significant changes, driven by advancements...
The stability of cannabinoid products is a critical factor for manufacturers aiming to deliver...
~ What the latest WHO reports tell us, and what they don’t ~
If you have a specific question for one of our scientific or regulatory experts, get in touch with a member of our team today.
